These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 865652)
1. Different sensitivity to antibiotics of the established intermitent in vivo--in vitro tumor cell lines in comparison with the primary cultures. Fusková A; Fuska J; Ivanitskaya LP; Makukho LV Neoplasma; 1977; 24():239-42. PubMed ID: 865652 [TBL] [Abstract][Full Text] [Related]
2. [Problem of screening of antineoplastic drugs in tissue and cell cultures]. Dobrynin IaV Eksp Onkol; 1985; 7(2):9-15. PubMed ID: 4006851 [TBL] [Abstract][Full Text] [Related]
3. [Uptake of radioactive precursors for the evaluation of sensitivity of anticancer drugs against cancer cells]. Ichihashi H; Kondo T Gan No Rinsho; 1984 Jul; 30(9 Suppl):1130-8. PubMed ID: 6471419 [TBL] [Abstract][Full Text] [Related]
4. Some new aryl-sydnones: effects on murine tumours. Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354 [TBL] [Abstract][Full Text] [Related]
5. A methodological approach to the prediction of anticancer drug effect in humans. Durkin WJ; Ghanta VK; Balch CM; Davis DW; Hiramoto RN Cancer Res; 1979 Feb; 39(2 Pt 1):402-7. PubMed ID: 761212 [TBL] [Abstract][Full Text] [Related]
6. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents. Volm M Behring Inst Mitt; 1984 May; (74):273-84. PubMed ID: 6383325 [TBL] [Abstract][Full Text] [Related]
7. The primary cultures of animal ascites tumor cells growth in tubes in suspension as a model in the screening of antitumor agents. Ivanitskaya LP; Makukho LV Neoplasma; 1975; 22(1):105-7. PubMed ID: 1153034 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines. Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231 [TBL] [Abstract][Full Text] [Related]
10. Cell survival following treatment with antitumor drugs. Roper PR; Drewinko B Cancer Res; 1979 Apr; 39(4):1428-30. PubMed ID: 421227 [No Abstract] [Full Text] [Related]
11. Potential of continuous tumour cell lines for establishing patterns of cross-resistance and collateral sensitivity in vitro. Hill BT Drugs Exp Clin Res; 1986; 12(1-3):293-8. PubMed ID: 3732052 [TBL] [Abstract][Full Text] [Related]
12. [Anti-blastic properties of berberine and its derivatives]. Shvarev IF; Tsetlin AL Farmakol Toksikol; 1972; 35(1):73-5. PubMed ID: 5011522 [No Abstract] [Full Text] [Related]
13. [Cytotoxic changes in the nucleic acid content in a culture of tumor and normal cells as affected by a complex preparation from Bacillus mesentericus AB-56]. Khomiak OG; Volynets AK; Gushcha KP Mikrobiol Zh (1978); 1981; 43(5):650-6. PubMed ID: 6171711 [No Abstract] [Full Text] [Related]
14. Preclinical studies and clinical correlation of the effect of alkylating dose. Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059 [TBL] [Abstract][Full Text] [Related]
15. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor. Socaciu C; Bara A; Silvestru C; Haiduc I In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268 [TBL] [Abstract][Full Text] [Related]
16. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds]. Ivanitskii LP; Makukho LV Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738 [No Abstract] [Full Text] [Related]
17. Alkylphosphonium salts as a new class of antitumor agents. Sanyal U; Chatterjee RS; Das SK; Chakraborti SK Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684 [TBL] [Abstract][Full Text] [Related]
18. [The use of tumor cells for the primary screening of antineoplastic antibiotics]. Ivanitskaia LP; Makukho LV Antibiotiki; 1969; 14(3):221-5. PubMed ID: 5409249 [No Abstract] [Full Text] [Related]
19. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids. Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528 [No Abstract] [Full Text] [Related]
20. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents. Ghosh M; Dutta S; Sanyal U Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]